Buyer Database · Buyer / Distributor · Updated
Blumhouse
Blumhouse is the defining low-budget horror studio, aggressively expanding its franchise portfolio and Gen Z-targeted originals while deepening its television and IP adaptation pipeline.
Current mandate
Blumhouse occupies a singular position in the horror market: a studio-backed production and distribution entity that has built its identity around low-budget, high-concept genre films and is now aggressively consolidating franchise IP. The company's acquisition of The Exorcist franchise rights, reported at $400M, signals a strategic pivot toward owning legacy horror properties outright rather than simply producing one-off entries. Simultaneously, the Saw franchise has entered the Blumhouse orbit, reinforcing a pattern of betting on established horror brands with built-in audience loyalty. These moves position Blumhouse not merely as a horror producer but as a horror rights library in formation.
On the originals side, Blumhouse Television has been doubling down on literary IP, securing rights to Clemence Michallon's upcoming second novel "Our Last Resort" as recently as May 2025. The comic adaptation "Something Is Killing the Children" is also in the pipeline, reflecting an appetite for genre material with pre-existing fan communities. The Black Phone sequel, directed by Scott Derrickson, represents the company's internal franchise development at its most deliberate: Derrickson structured the film as a high school horror entry, consciously escalating violence and scale relative to the first film, and shot dream sequences on Super 8 to create a visually distinctive aesthetic. The company's seeking statement explicitly names YouTube-native filmmakers with built-in audiences and original, low-budget horror concepts with strong Gen Z appeal as current priorities.
Material reaches Blumhouse primarily through established industry relationships, sales agents, and festival circuits where genre films surface. Blumhouse Television's literary acquisitions suggest that book-rights deals brokered through literary agents and publishers represent a documented route into the company's development pipeline. No open submission portal or named fellowship program is currently documented in tracked data, meaning no unsolicited pathway is documented for unrepresented writers at this time.
Signature peaks
- $400M Franchise IP Consolidation — Reported price for The Exorcist franchise rights acquisition, the company's most significant IP bet to date.
- 86 Active Decision Makers — ScriptMatch tracks 86 decision makers across Blumhouse's film and television operations.
- 165 12-Month Signal Volume — Total tracked records over the past 12 months, reflecting sustained market activity across acquisitions and development.
Mandate dimensions
- Genre focus
- Not disclosed
- Territory focus
- Not disclosed
- Budget tier (observed)
- Not disclosed
- Access pattern
- Tracked deals show material reaching Blumhouse primarily through literary agents brokering novel and IP rights, sales agents representing genre projects, and long-standing filmmaker relationships such as the ongoing Scott Derrickson collaboration. Blumhouse's public seeking statement targeting YouTube-native filmmakers with built-in audiences suggests that a documented platform presence and proven horror instincts represent an observed, if informal, route into the company's consideration set; no open submission portal or named fellowship program is currently documented.
- Deal structure
- Blumhouse structures deals across outright franchise rights acquisitions (as with The Exorcist and Saw properties), literary IP option and rights deals brokered through publishing channels, and production financing for internally developed originals distributed theatrically or via streaming partners.
Recent acquisitions
-
Saw franchise
-
Something Is Killing the Children
-
The Exorcist franchise rights
Market context
With The Exorcist franchise rights, the Saw franchise, and Black Phone 2 in motion, Blumhouse is consolidating horror's most valuable IP under one roof.
Blumhouse occupies a singular position in the horror market: a studio-backed production and distribution entity that has built its identity around low-budget, high-concept genre films and is now aggressively consolidating franchise IP. The company's acquisition of The Exorcist franchise rights, reported at $400M, signals a strategic pivot toward owning legacy horror properties outright rather than simply producing one-off entries. Simultaneously, the Saw franchise has entered the Blumhouse orbit, reinforcing a pattern of betting on established horror brands with built-in audience loyalty. These moves position Blumhouse not merely as a horror producer but as a horror rights library in formation.
Common questions about Blumhouse
Does Blumhouse accept unsolicited scripts?
No unsolicited pathway is documented in ScriptMatch's tracked data for Blumhouse. Every deal observed in the pipeline has moved through sales agents, literary agents brokering book rights, or established filmmaker relationships. Blumhouse's seeking statement does name YouTube-native filmmakers with built-in audiences as a current priority, suggesting that a demonstrable platform and horror track record can open doors, but no open submission portal or named program is on record.
What budget range does Blumhouse work at?
Blumhouse built its reputation on low-budget horror, and its current seeking statement explicitly calls out low-budget horror concepts as a priority. The company's model has historically involved modest production budgets paired with wide theatrical releases, generating outsized returns. Recent franchise acquisitions, including The Exorcist rights reportedly at $400M, show the company is also willing to make large rights investments when the IP warrants it, but originals development remains anchored in the low-budget tier.
What festivals does Blumhouse source films from?
Blumhouse's acquisition pattern, as tracked by ScriptMatch, skews toward IP-driven deals, literary adaptations, and internally developed projects rather than festival pickups. That said, genre festivals and markets remain a documented route for horror films to surface in front of major buyers. Blumhouse's focus on Gen Z-targeted horror and YouTube-native filmmakers suggests that platform-proven work, not just festival laurels, is increasingly a viable entry point into their consideration set.
How do I get my script in front of Blumhouse?
The most documented routes into Blumhouse's pipeline are through literary agents (for book-based IP, as seen with the Clemence Michallon acquisition), sales agents representing genre projects, and established filmmaker relationships. Blumhouse Television's active pursuit of novel rights suggests that writers with published or soon-to-be-published genre fiction have a viable path via literary representation. The company's stated interest in YouTube-native filmmakers with built-in audiences also points to platform-building as a credible strategy.
What genres is Blumhouse currently acquiring?
Horror is the core mandate, with a current emphasis on Gen Z-targeted concepts and franchise IP. Recent acquisitions span legacy horror franchises (The Exorcist, Saw), comic adaptations with horror-adjacent fan bases (Something Is Killing the Children), and literary thriller IP (Our Last Resort by Clemence Michallon). Scott Derrickson's Black Phone 2 reflects the company's internal appetite for elevated, thematically layered horror that can sustain franchise sequels without retreading prior entries.
Is Blumhouse currently active in the market?
Yes. ScriptMatch's pipeline shows 165 tracked records over the past 12 months and a latest signal as recent as July 2026, indicating sustained activity. The company has made several notable acquisitions in the recent period, including The Exorcist franchise rights, the Saw franchise, Something Is Killing the Children, and the novel rights to Our Last Resort. Blumhouse Television is also actively expanding its literary IP pipeline, signaling parallel activity on both the film and television sides.
Adjacent buyers in this lane
- Beta Cinema — Beta Cinema is a Munich-based international sales agent specializing in arthouse and literary-adapta
- Starz — Starz is a premium cable and streaming network doubling down on wholly owned scripted drama and inte
- Cineflix Rights — Cineflix Rights is a genre-focused international distributor and co-production financier specializin
- Filmax — Filmax is a Spanish distributor and co-producer with a long track record in genre cinema, currently
Related reading
Match your script to Blumhouse
This is a public snapshot of Blumhouse, kept current from trade-press signals. Inside ScriptMatch, upload your script to see whether Blumhouse fits, why, and exactly how to reach them. Start a card-required 7-day trial or try the no-card buyer-match tool.